Terms: = Prostate cancer AND USP6, TRE2, 9098, ENSG00000129204, TRE17, Tre-2, HRP1
7 results:
1. Benefits and harms of prostate specific antigen testing according to Australian guidelines.
Caruana M; Gulati R; Etzioni R; Barratt A; Armstrong BK; Chiam K; Nair-Shalliker V; Luo Q; Bang A; Grogan P; Smith DP; O'Connell DL; Canfell K
Int J Cancer; 2024 Feb; 154(4):648-658. PubMed ID: 37819139
[TBL] [Abstract] [Full Text] [Related]
2. Dual attention guided multiscale neural network trained with curriculum learning for noninvasive prediction of Gleason Grade Group from MRI.
Hu J; Shen A; Qiao X; Zhou Z; Qian X; Zheng Y; Bao J; Wang X; Dai Y
Med Phys; 2023 Apr; 50(4):2279-2289. PubMed ID: 36412164
[TBL] [Abstract] [Full Text] [Related]
3. Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective study.
Schmidt-Hegemann NS; Kroeze SGC; Henkenberens C; Vogel MME; Kirste S; Becker J; Burger IA; Derlin T; Bartenstein P; Eiber M; Mix M; la Fougère C; Müller AC; Grosu AL; Combs SE; Christiansen H; Guckenberger M; Belka C
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1852-1863. PubMed ID: 32002591
[TBL] [Abstract] [Full Text] [Related]
4. An eco-friendly catalytic system for multicomponent, one-pot synthesis of novel spiro-chromeno indoline-triones and their anti-prostate cancer potentials evaluated via alkaline phosphatase inhibition mechanism.
Kumar MR; Manikandan A; Sivakumar A; Dhayabaran VV
Bioorg Chem; 2018 Dec; 81():44-54. PubMed ID: 30118985
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-suppression function of transcription factor USF2 in prostate carcinogenesis.
Chen N; Szentirmay MN; Pawar SA; Sirito M; Wang J; Wang Z; Zhai Q; Yang HX; Peehl DM; Ware JL; Sawadogo M
Oncogene; 2006 Jan; 25(4):579-87. PubMed ID: 16186802
[TBL] [Abstract] [Full Text] [Related]
6. Determining the sensitivity of transrectal ultrasonography on a consecutive series of prostate cancers in a clinical and screening setting.
Ciatto S; Bonardi R; Lombardi C; Zappa M; Gervasi G
Tumori; 2002; 88(4):281-3. PubMed ID: 12400977
[TBL] [Abstract] [Full Text] [Related]
7. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.
Bolla M; Collette L; Blank L; Warde P; Dubois JB; Mirimanoff RO; Storme G; Bernier J; Kuten A; Sternberg C; Mattelaer J; Lopez Torecilla J; Pfeffer JR; Lino Cutajar C; Zurlo A; Pierart M
Lancet; 2002 Jul; 360(9327):103-6. PubMed ID: 12126818
[TBL] [Abstract] [Full Text] [Related]
